Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
about
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal healthProbiotics for the treatment of bacterial vaginosisThe effects of antimicrobial therapy on bacterial vaginosis in non-pregnant womenFrom structure to function: the ecology of host-associated microbial communitiesIs there a role for probiotics in the prevention of preterm birth?The human microbiome and probiotics: implications for pediatricsHuman lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.Lactobacillus crispatus L1: high cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens.Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics eraExtended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEWA systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal womenTreatment of bacterial vaginosis: a multicenter, double-blind, double-dummy, randomised phase III study comparing secnidazole and metronidazole.Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials.Treatment of bacterial vaginosis: what we have and what we miss.Recommendations for probiotic use in humans-a 2014 updateLactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond.Antibacterial treatment of bacterial vaginosis: current and emerging therapiesPURLs: Help for recurrent bacterial vaginosis.Probiotics to counteract biofilm-associated infections: promising and conflicting dataProbiotics: the potential for a live microbicide to prevent HIV.Bacterial vaginosis: Etiology and modalities of treatment-A brief note.Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infectionRestoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges.Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trialBiotherapeutic agents and vaginal health.Lactobacilli require physical contact to reduce staphylococcal TSST-1 secretion and vaginal epithelial inflammatory response.The Probiotics in Pregnancy Study (PiP Study): rationale and design of a double-blind randomised controlled trial to improve maternal health during pregnancy and prevent infant eczema and allergy.Efficacy and safety of a vaginal medicinal product containing three strains of probiotic bacteria: a multicenter, randomized, double-blind, and placebo-controlled trial.Probiotics to prevent the need for, and augment the use of, antibiotics.Demonstration of vaginal colonization with GusA-expressing Lactobacillus jensenii following oral delivery in rhesus macaques.A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis.Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial.Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.Vaginal microbiota and the use of probiotics.Vaginal lactobacilli as potential probiotics against Candida SPP.Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study.
P2860
Q21129223-5CD04664-AC92-4DCC-9DF9-4A55DA10D2F9Q24240103-E296FB39-63EA-430F-A4EF-85F872706E2FQ24241779-D28F21F7-4248-45EF-8D71-11464EC48AE1Q24612050-8685D584-BDF9-4DB4-827E-AB1BC3391D35Q26825756-2268538A-4164-41B1-81E3-058F98D100DAQ28750959-CD1B199B-A1FC-4C7F-B08B-6351889DE86FQ33314975-240F2D6D-74D7-4FDC-B151-5E3FA0A4D7D8Q33745803-8F23C608-1C29-4294-9692-BEE98152C85CQ33939802-20E6DBDD-79B3-47E6-8EBC-1B5647AD1EE2Q33997785-064BF7F3-C139-4900-94F3-B116724A9F6EQ34013627-CA4627C5-9C1D-4814-A363-0FFA621B5749Q34050627-A9D0C865-E029-4286-A6E0-0B09BA5D63ABQ34159369-E83209BA-1C40-4966-AF7D-A583A9CCC978Q34390550-23E901E7-208B-448B-9FF3-C0728376A6F9Q34407439-4CC9F6E5-33BF-4DDD-B06E-C362A03CA350Q34411373-6D26B845-3395-41EF-BFEC-A9F065C8DF73Q34602921-3F331418-CF21-4CCE-B62A-B4D283CD3F84Q34989914-365B01AB-AC73-4601-8EFB-C3EF4808CBAAQ35000008-98A4E004-69CD-47F9-ACFE-15C9122C567CQ35235235-ECE12EC3-06BF-462A-BDAA-D709B87E69F2Q35247486-4F7A898A-86E8-4D58-9DD5-78B77BF9928BQ35278680-74EBC1A9-0220-4CB3-BD84-5285278E2E73Q35575903-E96A1D44-6998-4508-B1B0-61CC06C0DEBFQ35646141-C1A265BB-EFA9-44FB-968C-17B1FE9503AEQ35678576-DFD366F8-74B2-434E-AF00-3628B842DAACQ35682766-E7DF8D13-2279-4E9F-9B6F-BB9F9C7C3007Q35800667-869876E7-2449-4BAC-AA5D-20AB8B36D0DCQ35860581-172D8F3B-BD43-4E5D-80C7-AAFAFE9B2A26Q35891684-FDAB00D0-EBB5-4465-98CA-D02F21C484B1Q35984227-C412455E-8937-4BDB-9B21-DFB32A732E8EQ36038452-BD3A80A1-47F9-4A87-88E5-7F77404B85CFQ36110963-B5DCB40C-E9A7-45A7-96B7-B85B8BD28B36Q36171266-28F06167-CDE6-4C0D-8768-90C0EED32917Q36254221-20B1C40C-521A-439C-AE62-33B8CA17A20BQ36516482-0B2F6703-1A29-455E-B29E-7E481EEFA6FCQ36543268-792E5991-25C0-438D-A6A3-8CF07CB78CB8Q36807314-389E6875-C170-4326-80E4-4C9649EA8D01Q37142995-3E6CA62F-A90E-4FD6-BC2A-C97C38EF0EB2Q37159489-E4F2220A-55A4-4300-9CBE-D9A0D01A8D3CQ37222371-B0B38C34-97AC-462C-864B-FF684344C8C1
P2860
Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@ast
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@en
type
label
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@ast
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@en
prefLabel
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@ast
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@en
P2093
P1476
Augmentation of antimicrobial ...... ind, placebo controlled trial.
@en
P2093
Andrew W Bruce
Emmanuel Osazuwa
Gibson Osemene
Gregor Reid
Ijeoma Ahonkhai
Kingsley Anukam
Michael Ngwu
P304
P356
10.1016/J.MICINF.2006.01.003
P577
2006-03-29T00:00:00Z